Skip to content

Inr Tracking Coumadin Use With Phone App

Inr Tracking With Face-To-Face And Phone App: A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05715541
Enrollment
24
Registered
2023-02-08
Start date
2021-06-01
Completion date
2022-11-30
Last updated
2023-02-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mobile Applications, Warfarin

Brief summary

This study aims to compare the INR values of the patients followed by face-to-face and telephone applications.

Detailed description

Warfarin has a narrow therapeutic window. Maintaining the patient's international normalized ratio (INR) within the predefined therapeutic range is one of the main challenges of warfarin treatment. This study was designed as a randomized controlled experiment. Twelve patients living in a distant place were assigned to the experimental group, and 12 patients living nearby and followed in the outpatient clinic were assigned to the control group. A Patient Information Form and the Adherence to Refills and Medications Scale were used to collect data.

Interventions

OTHERmobile applications with the name Set My INR

The relevant software company assisted in developing the phone application. The language of the application created with the name Set My INR is Turkish. The application provided an opportunity for patients to share and communicate with their physician after having the INR value measured in a health institution near their place of residence before coming to the hospital

Sponsors

Muhammed Onur Hanedan
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 90 Years
Healthy volunteers
No

Inclusion criteria

* at least 18 years old, using a smartphone, not having a psychiatric illness or treatment, and agreeing to participate

Exclusion criteria

* requiring medical examination, not using a smartphone, having a psychiatric illness or treatment, and not agreeing to participate

Design outcomes

Primary

MeasureTime frameDescription
Comparison of the Knowledge Levels of the Groups on the Use of CoumadinIt ranges from 6 months to 1 yearTo measure the knowledge level with Patient Information Form of patients using coumadin about the medication.
Comparison of INR Control and Drug Compliance Values by GroupsIt ranges from 6 months to 1 yearMeasuring medication compliance with The Adherence to Refills and Medications Scale of patients using coumadin. To compare the INR values of the patients using the phone application and followed face to face.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026